PAR paradigm biopharmaceuticals limited..

Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS, page-7

  1. 8,420 Posts.
    lightbulb Created with Sketch. 257
    it is....platform tech for a number of conditions potentially...“This proof-of-concept preclinical study has provided very exciting results for our drug, pentosan polysulfate sodium (PPS) and it again demonstrates PPS is a platform technology"...Rennie
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.5¢
Change
0.005(1.19%)
Mkt cap ! $168.9M
Open High Low Value Volume
42.5¢ 43.5¢ 42.0¢ $73.05K 171.3K

Buyers (Bids)

No. Vol. Price($)
3 32728 42.5¢
 

Sellers (Offers)

Price($) Vol. No.
43.5¢ 7738 3
View Market Depth
Last trade - 11.28am 15/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.